Biological Material Analysis TRIZ Cases

Alternating gold and ferromagnetic layers reduce antibody interference while FRET enables sensitive cytokine quantification.

Automated cartridges reduce manual errors in glycated hemoglobin testing.

Trypsin followed by neutrophil elastase creates analyzable fragments for BiTE® modification monitoring and mass spectrometry.

This case uses sodium deoxycholate to lyse blood cells without affecting CRP, while trehalose or sucrose supports reagent stability.

This case uses CDR extraction and phage display screening to produce a high-affinity SARS-CoV-2 nanobody for neutralization.

Conventional detection can miss subtle disease; sADAM9v2-specific antibody binding supports earlier, more precise prostate cancer detection.

A multi-electrode biosensor combines EIS with voltammetry or amperometry for frequent, user-friendly cyanotoxin monitoring in water.

Photoconvertible fluorescent proteins and AI automate droplet imaging, classification, sorting, and recovery at high throughput.

Lectin-coated silicon nanowires use photocurrent to measure glycosylation states in real time.

Cell property changes, mechanical characterization, and fluorescence analysis support high-throughput detection of multiple biomolecules.

This assay uses 3–8 hours of PHA stimulation and IFNγ measurement to assess immune status without specialized flow cytometry.

Histidine scanning tunes anti-Her2 affinity for acidic tumors while limiting binding and toxicity in normal tissues.

Localized optothermal bubbles drive convection at the bubble interface, improving biomolecular sensing speed and sensitivity.

Combining LSPR phase sensing with antibody-functionalized AFM imaging improves specific, non-invasive detection of glioma exosomal proteins.

This CDC assay case uses rapid or pre-added complement to reduce nonspecific cytotoxicity and improve precision.

Covalently bound HBs antigen particles are washed with mild surfactants or acidic solution to remove impurities and improve sensitivity.

Separate microwells and labeled binding substances help identify target cells with fewer false positives and greater analysis capacity.

Covalent HBs antigen binding followed by surfactant or acidic washing removes impurities while preserving antigenic determinants.

A phosphorylcholine copolymer inhibits nonspecific reactions in antigen-antibody assays, improving accuracy without reducing sensitivity.

Chemically synthesized peptides enable rapid, sensitive norovirus detection.

Hydrophilic, hydrophobic, and isoelectric-point differences in α-amino acid receptors classify volatile compounds more reliably.

Radiolabeled VHH polypeptides support high-resolution, quantitative ECT imaging of PD-L1-expressing tumors for early diagnosis.

EVTRAP uses hydrophilic and aromatic lipophilic bead groups to isolate EVs from biofluids in about an hour with high recovery.

Bemarituzumab dosing regimens target FGFR2b signaling to inhibit growth in selected solid tumors after conventional therapy.

Enzymatic digestion, peptide purification, and wide-window LC-MS address dynamic range limits in low-abundance AAV HCP detection.

This in vitro assay normalizes soluble TNFR2 to total protein, improving reproducibility when evaluating MSC immunomodulatory activity.

Protein surrogates and spectrophotometry enable faster, accurate aluminium hydroxide checks in MenB vaccine production.

Machine learning ranks likely natural protein variants before testing, helping generate functional antibodies for viral antigen binding.

Immunochromatographic strips enable home blood counts with smartphone telemedicine.

This case uses scalable anti-HLA-G VHH nanobodies to block immune suppression and enable HLA-G expression detection and cancer treatment.

A defined PD-L1 epitope and monoclonal antibody format improve reproducible detection in fixed tumor samples for patient stratification.

This case uses high-affinity anti-TIGIT antibodies to block TIGIT-PVR binding and enhance cytokine release and NK cell function.

Magneto-optical hemozoin detection enables timely malaria diagnosis at the point of care.

Measure Eomes in memory T cells to identify rejection risk and adjust immunosuppression for transplant tolerance.

Capture exosomes through CD9, CD63, CD81, or CD82 to improve sandwich immunoassay specificity without target material.

SELDI mass spectrometry and immunoassays combine protein biomarkers to distinguish ovarian cancer from benign disease.

This case pairs tripeptide-guided Hip1 inhibition with a lateral flow assay for faster TB diagnosis and lower treatment toxicity.

This case combines chemotherapy with KIR3DL2-targeted antibodies to selectively deplete tumor cells in aggressive PTCL.

Two fluorescent dyes and optical signals combine leukocyte and infected erythrocyte detection, reducing blood volume and test costs.

This case develops gp120-binding human monoclonal antibodies that block HIV-1 entry across diverse clades.

This case uses fluorescent substrates and antibody-coated magnetic beads to detect abrin toxin quickly without mass spectrometry.

This case uses labeled proteins, a quencher, and response curves to distinguish ternary complexes from binary formations.

This case uses engineered VH and VL CDR sequences to target CEACAM6-expressing cancer cells for therapy and detection.

A modified copy of the analytical antibody intercepts heterophilic antibodies and rheumatoid factors, improving immunoassay reliability.

High-pressure carbon dioxide creates hierarchical wrinkled networks without heat or solvents that can denature biomolecules.

A near-copy antibody with one to three residue changes blocks interfering antibodies while supporting accurate analyte detection.

Different waiting periods and waveform analysis identify coagulation-time causes without mixing subject and normal plasma.

This case uses TSHR-specific antibodies to reduce hyaluronic acid and cytokine secretion in orbital fibroblasts.

This case uses selective humanized anti-SIRPa antibodies to block SIRPa-CD47, avoiding SIRPg binding and T-cell inhibition.

Specific Fc substitutions enhance CD40 agonism after crosslinking, supporting anti-tumor activity at safer, tolerable doses.